Itamar Medical Ltd - ADR
ITMR
Market Cap$0
Close$
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.79 |
| Beta | 0.54 |
| Outstanding Shares | 16,411,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -39.08 |
|---|---|
| PEG | -20.64 |
| Price to Sales | 15.44 |
| Price to Book Ratio | 7.72 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Itamar Medical Ltd.
CEO: Gilad Glick Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The ...